Inventor
James Paul LAJINESS
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds24%
C12NMicroorganisms or enzymes14%
A61LMethods or apparatus for sterilising materials or objects in general7%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
12,365,6926-hydroxy-8-oxatricyclo[3.2.1.02,4]octane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage202512,280,041Compounds and compositions for inducing chondrogenesis202512,257,2435-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage202512,209,096Compounds and compositions for inducing chondrogenesis202511,753,416Compounds and compositions for inducing chondrogenesis202311,510,912Compounds and compositions for inducing chondrogenesis202211,203,595Aza-indazole compounds for use in tendon and/or ligament injuries2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to NOVARTIS AG (7)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 7 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |